Special Issue "Personalized Medicine in Spondyloarthritis"
Deadline for manuscript submissions: 15 March 2024 | Viewed by 188
Interests: immune-mediated inflammatory rheumatic disorders; rheumatoid arthritis, spondyloarthritis; connective tissue diseases – systemic sclerosis, systemic lupus erythematosus, poli/dermatomyositis; biological therapies
Special Issues, Collections and Topics in MDPI journals
Spondyloarthritis (SpA) represents a heterogeneous group of rheumatic inflammatory entities involving the axial skeleton, enthesis, and peripheral joints and may occur together with extra-articular manifestations, such as psoriasis, inflammatory bowel disease, and uveitis.
Important advances in the understanding of SpA have been made in the area of classification criteria, significantly improving the approach to these diseases and the identification of patients in early stages of the disease. Numerous studies have elucidated the immune mechanisms underlying specific clinical manifestations of the disease, opening the way to new and more personalized therapeutic approaches. In particular, new and more specific treatments promise to make feasible treat-to-target and drug-free remission in SpA, which were once impossible objectives. Although the diagnostic delay in SpA is still considerable, the increased awareness and insights into diagnosis at early stages of the disease are contributing to improving its management.
The present Special Issue aims to deepen the knowledge of SpA from bench to bedside, providing a broad update on the pathophysiological, diagnostic, and therapeutic aspects of the disease.
Prof. Dr. Codrina Ancuta
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- diagnostic biomarkers
- therapeutic biomarkers
- spondyliarthritis comorbidities
- genetics of SpA
- pathophysiology of SpA
- established therapeutic approaches in SpA
- new therapeutic approaches in SpA